miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1

TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis

(2016) Joanne Hsieh et al.   NATURE

A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation

(2015) Brenda S. Hijmans et al.   FASEB JOURNAL

Amino Acid Deprivation Promotes Tumor Angiogenesis through the GCN2/ATF4 Pathway

(2015) Yugang Wang et al.   NEOPLASIA

Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease

(2014) Yue Ying Feng et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

(2014) Carlos J Pirola et al.   GUT

miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1

(2014) Chenchao Ma et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF

(2014) Li-qiang Wei et al.   TUMOR BIOLOGY

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease

(2013) Hisamitsu Miyaaki et al.   LIVER INTERNATIONAL

MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion

(2013) James Soh et al.   NATURE MEDICINE

Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212

(2013) Xiuming Liang et al.   PLoS One

Mechanisms for Insulin Resistance: Common Threads and Missing Links

(2012) Varman T. Samuel et al.   CELL

Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α

(2012) Eric A. Hanse et al.   CELL CYCLE

Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome

(2012) Carlos J. Pirola et al.   HEPATOLOGY

Amino acid deprivation regulates the stress-inducible gene p8 via the GCN2/ATF4 pathway

(2011) J. Averous et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?

(2011) Anne P.L. Jensen-Urstad et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis

(2011) S. Ducheix et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Leucine Deprivation Increases Hepatic Insulin Sensitivity via GCN2/mTOR/S6K1 and AMPK Pathways

(2011) Fei Xiao et al.   DIABETES

Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice

(2011) Menno Hoekstra et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Epigenetic Regulation of miR-212 Expression in Lung Cancer

(2011) Mariarosaria Incoronato et al.   PLoS One

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

(2011) N. Kumashiro et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic control ofde novolipogenesis: role in diet-induced obesity

(2010) Maggie S. Strable et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c

(2010) P. Ferré et al.   DIABETES OBESITY & METABOLISM

The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation

(2010) Jiangbin Ye et al.   EMBO JOURNAL

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

(2010) Giovanni Musso et al.   HEPATOLOGY

Lipid-induced insulin resistance: unravelling the mechanism

(2010) Varman T Samuel et al.   LANCET

miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development

(2010) Ahmet Ucar et al.   NATURE GENETICS

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Effect of Alcohol on miR-212 Expression in Intestinal Epithelial Cells and Its Potential Role in Alcoholic Liver Disease

(2008) Yueming Tang et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease

(2008) X. Jin et al.   DIGESTIVE AND LIVER DISEASE

ChREBP: A Glucose-activated Transcription Factor Involved in the Development of Metabolic Syndrome

(2008) Katsumi IIZUKA et al.   ENDOCRINE JOURNAL

Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice

(2008) Qiong Wang et al.   HEPATOLOGY

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

(2008) Catherine Postic et al.   JOURNAL OF CLINICAL INVESTIGATION

Non-alcoholic fatty liver disease: The mist gradually clears

(2008) Nimantha Mark Wilfred de Alwis et al.   JOURNAL OF HEPATOLOGY